The association of pre-diabetes with significant coronary artery disease and ischemic mitral regurgitation in patients with non-ST-segment elevation acute coronary syndrome

非ST段抬高型急性冠脉综合征患者中,糖尿病前期与显著冠状动脉疾病和缺血性二尖瓣反流的关联

阅读:1

Abstract

BACKGROUND: Pre-diabetes is associated with an increased risk of developing cardiovascular disease (CVD). We aimed to investigate the association between pre-diabetes and the severity of coronary artery disease, along with other high-risk markers-such as ischemic mitral regurgitation (MR)-in non-diabetic patients hospitalized with NSTE-ACS. METHODS: This study was a case control study on 200 non-diabetic patients including equal size of consecutive pre-diabetic and normoglycemic individuals with NSTE-ACS. All patients underwent an echocardiography to determine the left ventricular ejection fraction, prevalence and existence of ischemic mitral regurgitation (MR), and right ventricular size and function. After that, coronary angiography (CAG) was performed to assess the significance of coronary artery disease (CAD) and to calculate the SYNTAX score. RESULTS: pre-diabetic patients were older and had higher prevalence of hypertension than normoglycemic group (P value<0.001 and 0.001, respectively). Also, significant CAD (86 % vs. 74 %, P value = 0.034) and severe ischemic MR (16 % vs. 6 %, P value = 0.024) were more prevalent in pre-diabetic patients than in normoglycemic patients, whereas the absence of MR was more common in normoglycemic patients (21 % vs. 3 %, P value <0.001). The logistic regression analysis showed the association between significant CAD and pre-diabetes was independent of other variables (P value = 0.049, odds ratio [OR]: 2.402, 95 % CI: 1.005-5.741). CONCLUSIONS: In our study, severe CAD and ischemic MR were more prevalent in pre-diabetic patients than normoglycemic ones that may be indicative of pre-diabetes as a high risk state in NSTE-ACS.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。